MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 71 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,697,460 | -33.1% | 3,694,668 | -4.3% | 0.00% | 0.0% |
| Q2 2023 | $26,443,438 | -6.0% | 3,860,356 | +7.0% | 0.00% | 0.0% |
| Q1 2023 | $28,117,389 | +2.7% | 3,609,421 | +0.3% | 0.00% | 0.0% |
| Q4 2022 | $27,384,859 | -3.4% | 3,598,536 | +3.7% | 0.00% | 0.0% |
| Q3 2022 | $28,352,000 | -11.5% | 3,470,232 | +4.8% | 0.00% | 0.0% |
| Q2 2022 | $32,033,000 | -27.0% | 3,312,569 | +5.9% | 0.00% | 0.0% |
| Q1 2022 | $43,861,000 | -8.7% | 3,128,392 | +32.9% | 0.00% | 0.0% |
| Q4 2021 | $48,063,000 | +4.3% | 2,353,764 | +13.8% | 0.00% | 0.0% |
| Q3 2021 | $46,091,000 | +31.0% | 2,068,677 | +33.5% | 0.00% | 0.0% |
| Q2 2021 | $35,183,000 | – | 1,549,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |